Alnylam Pharmaceuticals, Inc. v. Pfizer Inc.
1:22-cv-00336
Overview
Parties
Defendant
Pharmacia & Upjohn Co. LLC Operating Company
Represented By
7 Attorneys ListedConnolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Connolly Gallagher LLP
1201 N. Market St., 20th Floor
Pfizer Inc. Operating Company
Represented By
7 Attorneys ListedConnolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Connolly Gallagher LLP
1201 N. Market St., 20th Floor
Plaintiff
Alnylam Pharmaceuticals, Inc. Operating Company
Represented By
9 Attorneys ListedMcDermott Will & Emery LLP
The Brandywine Building, 1000 N. West Street
Counter Claimant
BioNTech Manufacturing GmbH NPE (Individual / Inventor)
Represented By
4 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
BioNTech SE NPE (Individual / Inventor)
Represented By
6 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc.
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc.
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.
Patents Involved
There are 6 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US11246933
Biodegradable lipids for the delivery of active agents
|
Filed: 2021-04-29
Issued: 2022-02-15
|
Active (14.4 yrs remaining)
Expires: 2041-04-29
|
|
|
US11382979
Biodegradable lipids for the delivery of active agents
|
Filed: 2021-12-17
Issued: 2022-07-12
|
Active (15.1 yrs remaining)
Expires: 2041-12-17
|
|
|
US11633479
Biodegradable lipids for the delivery of active agents
|
Filed: 2022-02-14
Issued: 2023-04-25
|
Active (15.2 yrs remaining)
Expires: 2042-02-14
|
|
|
US11633480
Biodegradable lipids for the delivery of active agents
|
Filed: 2022-02-14
Issued: 2023-04-25
|
Active (15.2 yrs remaining)
Expires: 2042-02-14
|
|
|
US11612657
Biodegradable lipids for the delivery of active agents
|
Filed: 2022-02-14
Issued: 2023-03-28
|
Active (15.2 yrs remaining)
Expires: 2042-02-14
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
142
Dispositive
0
Granted
2
Denied
2
Pending / Review
58
Motions by Category
Key Dispositive Motions & Rulings